chrisvoncsefalvay/vaers-outcomes huggingface dataset:
I got my second COVID shot on 1/21/21 and a day or 2 later I started to lose my skin on my hands and the bottom of my feet. I went to my doctor and a dermatologist. They took skin samples and both doctors do not know what is cause my problems.
covid-19; covid-19; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 71-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), as dose number unknown, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "Osteoporosis" (unspecified if ongoing). No Known allergies. There were no concomitant medications. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "recovered" (23Jul2022) and all described as "covid-19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: positive, notes: COVID 19 Treatment. Therapeutic measures were taken as a result of drug ineffective, covid-19. The patient received Paxlovid as COVID 19 treatment from 10Jul2022 to 14Jul2022, covid rebound on 20Jul2022 and recovered on 23Jul2022. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Patient stated that they will refuse the second dose of the Pfizer vaccine based on side effects experienced since.  Complications include pain that felt like "lightning bolts", temporary loss of vision, and that their "mind went black" which has improved in the past few days.  Pt. believes that his recent cognitive decline is directly attributed to receiving the vaccine and expresses concern with whoever else gets it.
achy; crummy; sore arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (sore arm), PAIN (achy) and FEELING ABNORMAL (crummy) in an 18-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029A21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 11-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Mar-2021, the patient experienced PAIN IN EXTREMITY (sore arm). On 06-Apr-2021, the patient experienced PAIN (achy) and FEELING ABNORMAL (crummy). On 13-Mar-2021, PAIN IN EXTREMITY (sore arm) had resolved. At the time of the report, PAIN (achy) and FEELING ABNORMAL (crummy) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 05-Apr-2021, COVID-19: (Positive) Covid19 positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided.  Treatment medications were not provided.   Reporter did not allow further contact
dizzy, light-headed, ears ringing, fever, chills, nausea, diarrhea, sore / tender feet.
Employee stated felt hot and flushed 2-3 hours after vaccination and experienced nausea, fatigue, vomiting and diarrhea for 4 days after vaccination.
Information has been received from a RN concerning a 27 year old "healthy" female who on 16-JUN-2004 was vaccinated with a dose of MMR II. On 28-Jun-2004, the pt called her physician and reported a rash that "may have began over the previous weekend", on approximately 26-Jun-2004. A physician at another office diagnosed it as rubella. The rash was on her face, chest and back. It was a raised, red rash. She was treated with Benadryl cream or cortisone cream. Unspecified medical attention was sought. There was no product quality complaint involved. Follow-up information from the reporter indicated: "I have no recollection of contacting you re: this pt." We do not have this pt in our computer. No further information is expected.
Patient experienced redness and burning at the sight of injection. It was also swollen at the sight of injection.
I've had chicken pox like blisters arise on my right arm, left leg and stomach area near belly button. These have not gone away and it's been 2 months. New ones come but they are starting to calm down a slight bit. These pox blisters leave deep wounds when popped and are very itchy. The ones that are now gone have left scars that are hopefully temporary.
Pt has seizure to 104.6 F the evening of the vaccine and had febrile seizure at home.
Redness, painful, halo around injection site. Advised cold compress and pain reliever, call if new symptoms arise or worsening occurs.
Information has been received from a physician concerning an adult female with a concurrent condition of asthma and no known drug allergies who on 01/23/04 was vaccinated with a dose of varicella virus vaccine live (Lot # 642685/0328M) that had expired. The pt "has now", on approximately 02/12/04, "developed papular vesicular rash with lesions on the trunk and arms, with left eye conjunctivitis".  The pt was "non febrile".  Unspecified medical attention was sought. There was no product quality complaint involved.  Additional information has been requested.
Pt received her third dose of Hep B vaccine on 3/1/19 and reported on 3/2/19 she woke up with a HA, eye pain and an itchy rash all over her body. Pt called her insurance nurse hotline and was advised to take BENADRYL and to go to an urgent care for further follow-up. Pt went to an urgent care clinic. Reports she had a low grade fever and was given an rx for steroids. Clinic RN spoke with pt on 3/4/19 at which time pt reported she was feeling better since starting the steroids and would contact clinic if her sx continue or worsen. PCP, Dr. informed. Patient is a 60 y.o. female. Patient has chronic depression with insomnia, COPD with asthma, hep C and GERD and chronic pain from osteoarthritis severe of the hip and knees.
Patient was given pfizer vaccine @ approximately 2:30pm. @ approximately 2:41pm the patient was asked by the nurse "are you ok" and how are you feeling? Patient stated I'm feeling ok and per nurse patient eyes rolled in back of her head. Nurse immediately approached patient. vitals assessed, safety maintained, nurse asked mom questions, mom stated patient had not eaten prior to vaccine. patient felt warm to touch. Patient was given fluids and crackers. Ice pack placed underneath left arm.  Safety measures maintained. Vitals reassessed and within normal limits patient was monitored for 30 mins.  Nurse asked pt how she was feeling. pt stated fine.
pt recvd vax @ 12N-about 10sec p/inj; pt noted to have eyes roll back-limp-? sl shaking no color change responded by gentle shaking by crying;t100.5R a/;p/100R 120-28;02 sat 98%, Tp/30mins 99.8R
PATIENT FELT DIZZY AND NAUSOUS AFTER VACCINATION. PATIENT SAID HE LOST COLOR IN HIS VISION. PATIENT'S HEAD ROLLED AND THEN HIS WHOLE BODY BECAME STIFF BEFORE COMING BACK TO CONCIOUSNESS. PATIENT SAYS THIS HAPPENS WITH ALL VACCINATIONS AND DRAWING BLOOD.
no adverse event; M-M-R II was administered by the intramuscular rather than subcutaneous route to a 1 year; This spontaneous report was received from a Licensed Practical Nurse refers to a 1 year old female patient. The patient's pertinent medical history, drug reactions/allergies were not reported. The patient's concomitant medication included sterile diluent. On 16-MAY-2019, the patient was vaccinated with measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live recombinant human albumin (M-M-R II) (lot #: N034002, expiration date: 04-DEC-2019), intramuscularly for prophylaxis instead of subcutaneous route (incorrect route of product administration). No adverse effects reported. Both measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live recombinant human albumin (M-M-R II) and sterile diluent were properly stored. No adverse effects reported.   Product quality complaint not involved.
01/18/22 presents to ED for "chest pain". PMHx of "hyperlipidemia, obesity, hypertension, CABG in 2014, status post multiple catheterizations"
Malaise, lethargy, fever 101.4F, arm pain, body aches, wheezing
This spontaneous report as received from a pharmacist via field representative refers to a patient of unknown age and gender. On an unknown date, the patient was vaccinated with PNEUMOVAX 23 (lot #, dose and route not provided) one dose in the deltoid region of the arm. Other suspect therapies included, influenza virus vaccine (manufacturer unknown) coadministered (Lot number, dose and route not reported). On an unknown date, after receiving PNEUMOVAX 23 with influenza virus vaccine (manufacturer unknown) the patient developed swelling of the arm. On an unknown date, the patient went to the emergency room. At the time of the report, the swelling of the arm was unknown. This is one of two reports received from the same source. Additional information has been requested.
PT C/O HEADACHE, DROWSINESS, NAUSEA AND FELT LIKE HE HAD A FEVER.  PT VITAL SIGNS NORMAL APPEARED DROWSY.
sore arm; knot under arm; This case was reported by a other health professional via sales rep and described the occurrence of pain in arm in a 18-year-old male patient who received Men B NVS (Bexsero) (batch number ABX749AA, expiry date unknown) for prophylaxis.   On 30th April 2019, the patient received the 1st dose of Bexsero. On an unknown date, 1 day after receiving Bexsero, the patient experienced pain in arm and axillary lump. On an unknown date, the outcome of the pain in arm and axillary lump were unknown.   It was unknown if the reporter considered the pain in arm and axillary lump to be related to Bexsero.  Additional details were provided as follows: The patient had sore arm, knot under arm. Started next day and knot did not go away. Soreness lasted several days.  No adverse events reported on 2nd dose. The reporter agreed to follow up with GlaxoSmithKline.
This spontaneous report was received from a medical assistant who referred to an unspecified patient of unknown demographics. No information regarding the patient's pertinent medical history, concurrent conditions and drug reactions or allergies was provided. On 25-SEP-2017, the patient was vaccinated with one dose of improperly stored PNEUMOVAX23 lot # N014188 with expiration date: 22-JAN-2019 (route not reported) as prophylaxis. It was reported that the vaccine was stored in temperature between 47 degrees Fahrenheit (F) to 77F to 72 hours. No previous temperature excursions were reported. The temperature excursion was detected by a data logger. No adverse events were reported. No product quality complaint was involved.
This spontaneous report as received from a healthcare worker refers to an unknown number of patients of unknown ages and genders who might have been received improperly stored GARDASIL on unknown dates (dose, lot#, expiration date and route unknown). The vaccine were exposed to negative 2 centigrade for 30minutes on 01-NOV-2013. No adverse effect was reported. Additional information has been requested.
Complained of nausea, weakness, headache, approximately 5 minutes after injection.  V/S-Temperature: 98.2, 100, B/P: 96/63, spo2: 97%.  Note: within 1 minute after injection complained of nausea, shortness of breath.  09/14/2003: feels weak today.
A week after receiving vaccine, My arm swelled at injection site, it itched and was hot and red.
Within a week of receiving the second dose of the covid vaccination, I started having neurological  and some cardiovascular symptoms and still have many of those symptoms. They consist of profound fatigue, headaches, memory issues, dizziness, expressive aphasia, weakness, unsteady gait, shortness of breath/palpitations.
After administration, patient did not report any reaction and was asked to wait 15 minutes for monitoring. A few minutes later, he started feeling lightheaded and called his father. His father notified me that he was "spazzing out/seizing" with his head jerking backwards "for a couple seconds". When I saw the patient, he was sitting and unresponsive to verbal and physical stimuli with his father patting his cheek. After a minute or so, the patient was able to respond, but his voice was faint. He reported having a "severe headache" and feeling "sweaty". He had no fever or difficulty breathing. Father said there was no anaphylaxis, and asked for a bucket since the patient felt very nauseous. I then called 911 for emergency services. When I returned to the patient after the call, the father said he was feeling much better and that the "color had returned". Patient was unwilling to stand, and remaining symptom(s) was headache. Emergency services came and checked blood pressure, which was normotensive (SBP 111). Father insisted ER visit was not necessary.
First pain at sight - but instead of going away after a few days - 3 wks. later still sore if touched. Also I can't lift arm straight above head without a shooting pain or some side movements trigger a pain as well. Slightly better this last week.
1020 Dizzy and lightheaded after she sat down for observation time. After 5 minutes complained of tongue tingling.  No SOB , no swelling of the throat or lips. Vital signs normal. Injection  site , no swelling or redness noted.  Water was given to drink , no adverse reaction.  1040 Tongue tingling resolving.  Vital signs normal. 1100 All symptoms resolved and she was released to return to work per Occupational Health  Nurse.
five minutes after vaccination was given, became dizzy with blurred vision and then nausea with vomiting of less 100 ml. After 15 minutes all symptoms subsided except for dizziness. Employee was monitored, vitals are stable at BP 114/76 pulse is 59.  Care called, spoke to nurse , it was advised that employee continued to be monitored if symptoms become worse follow up with urgent care.
mom called 8/31 stated @ approx 545PM child had T103, was sleepy & pale;contacted MD & was unavailable so contacted ER @ local hosp;
father stated pt recvd vax 10AM & was pale & listless 1130; pt had t103 ax; temp came down w/APAP & bath but came back up w/in a few hrs; pt seen by MD on 3AUG93; CBC was drawn & pt was put on ATB; MD stated CBC revealed infection
This spontaneous report was received from a licensed practical nurse referring to an unspecified number of patients of unknown age and gender. There was no information about the patients' concurrent conditions, concomitant therapies or medical histories. On unknown dates since 24-APR-2017, the patients were vaccinated with improperly stored doses of PROQUAD (lot number M042499 with expiration date of 07-APR-2018, lot number M039448 with expiration date of 20-MAR-2018, lot number M033210 with expiration date of 09-JAN-2018 and lot number M031566 with expiration date of 24-DEC-2017; strength, dose, route and anatomical location were not provided), for prophylaxis. It was also reported that the administered doses experienced a temperature excursion during 15 minutes at a temperature between 6 degrees Fahrenheit and 14 degrees Fahrenheit on unspecified dates, and a temperature excursion during 1 hour 54 minutes at a temperature between 15 degrees Fahrenheit and 46 degrees Fahrenheit on unspecified dates. No previous temperature excursion was reported. A data logger issue was involved. No adverse experiences were reported. This is one of two reports received from the same reporter. Additional information has been requested.; Sender's Comments:  US-009507513-1705USA011317:
Fist-sized area of erythema, tenderness, warmth right thigh. No fever, no limp.
Local rxn rt deltoid ("handsize") swollen & painful; Local adenopathy (inj site); Angioneurotic edema.
This spontaneous report was received from nurse refers to a 16 month old patient of unknown gender. On 10-JUL-2014 the patient was vaccinated with an improperly stored VARIVAX lot # J012376 Expiration date: 03-OCT-2015, 0.5 ml, subcutaneous that was exposed to 13F for two hours. No adverse effects were reported. Additional information has been requested.
Vaccine was given 1 days after expiration from moving from the freezer to the refrigerator.
Seasonal Flu vaccine given at 4:45 PM. At 10:30 PM episode of atrial fibrillation began and continued on and off for 24 hours and counting. Previously atrial fibrillation symptoms had been absent for 3 months and had been very brief in duration for past 9 months.
Had stuffy nose, fatigue and cough. Next day chest heaviness and a headache. Home COVID-19 test - positive. Called Dr. and got a prescription for PAXLOVID. Retested a week later with a home COVID-19 test and it was negative.
a little diarrhea; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (diarrhea) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 043B21A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included LISINOPRIL, Isosorbide Monohydrate, ACETYLSALICYLIC ACID (ASPIRIN (E.C.)), PAROXETINE and PRAVASTATIN for an unknown indication.    On 14-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced DIARRHOEA (diarrhea). Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       This case was linked to MOD21-083701 (E2B Linked Report).; Sender's Comments:  MOD21-083701:cross linked id
MOC stated that patient was 5 years old at time of vaccination.  Pt was 4 years old at time of vaccination.   Immunization Information System check completed prior to vaccination, however, information found that child is 4 years old after vaccine administered through Immunization Information System.  Attempted to contact MOC.  Messages left.  Unable to contact MOC.
This spontaneous report was received from a nurse practitioner and refers to a 53 year old female patient. The patient's concurrent conditions, medical history, historical drugs and concomitant therapies were not reported. On an unknown date, the patient was vaccinated with an improperly stored dose of M-M-R II lot number R002930, expiration date 31-JAN-2019 (dose and route were not reported) for prophylaxis. No adverse effects were reported. The temperature involved was 49.4 degrees Fahrenheit for 12 hours. Previous temperature excursion was not reported, and a data logger was involved.
Pt developed swelling on left arm with redness and pruritus. Treated with warm compress and follow-up.
Patient arm became red/swollen/hot/itching "day or two" after immunization, initially area was about the size of palm but continued to spread down her arm. The patient reports taking one dose of oral  diphenhydramine and using diphenhydramine topically. The primary care provider was contacted today when the patient brought reaction to the attention of the pharmacy. The PCP advised the patient to use a warm compress and scheduled an office appointment for tomorrow afternoon 9/6/17.
Pt recvd vax & 2 days following vax exp somnolence, flu-like sx & pain on inject; sx resolved;
first dose 3 years ago / didn't complete the series; This case was reported by a pharmacist via call center representative and described the occurrence of incomplete course of vaccination in a female patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (received 1st dose on 23rd September 2018, batch number M77B4, expiry date 08th February 2019).   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the incomplete course of vaccination was unknown.  Additional details were provided as follows: The age at vaccination was not applicable for this report. Till the time of reporting, the patient did not receive 2nd dose of Shingrix, which led to incomplete vaccination schedule. The pharmacist did not know, whether to restart the series or give the second dose.  The pharmacist declined to provide patient details. The reporter did not consent to follow up.
Flu shot placed 10/26/06. She called on 11/6/2006 to report development of a rash 2-3 days later (10/27 or 10/28) at injection site, which reports was red & pruiritic. States 1 week later, she ate eggs and the rash and pruritis got worse. Developed rash on arms, L abdomen and L back and left upper thigh. General achiness. Not on new meds and is not immunosuppresed. On 11/6/06 rash resolving. "Rash" appears as nonfluid  filled red circles (largest size=size of a pencil eraser). Denied fever. Per infection control -informed to seek medical care. Not sure if patient has seen a doctor yet.
Patient has limited mobility in arm after Moderna booster she has been treating with lidocaine patches and NSAIDs. It has been going on since vaccination on 10/26/21 and is slowly improving
The day after the injection she noticed her arm was very red and warm around the injection site. It is a large area that is about 5 inches in diameter. On day 4 post-injection it was the same size.
Treatment of COVID-19; Treatment of COVID-19; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 67-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), in Feb2022 as dose 3 (booster), single (Batch/Lot number: unknown) at the age of 67 years, in right arm for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown) and as dose 2, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient had no relevant medical history. There were no concomitant medications. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "Treatment of COVID-19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Unknown results. Therapeutic measures were taken as a result of drug ineffective, covid-19.   Clinical course: Patient had no known allergies. Patient was not taking other medication in past 2 weeks. patient was taking treatment of Paxlvoid for covid 19, Treatment start date: 20Jun2022, Treatment stop date: 23Jun2022.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
Severe swelling in lymph nodes under arm that received the injection and still swollen and painful to this moment.  Fever for over 24 hours, highest it reached was 101.8.  Swelling and dead arm feeling in the arm that received the shot and still feeling it over 24 hrs later.
I get a pulsing sound and sensation in my left ear.  I have never had this before.  It comes and goes and feels like when your in a plan and the ears need to pop.  But after a few pulses it just disappears on its own.  \It has the bass sound feeling.
This spontaneous report was received from a nurse referring to a 15 year old female patient. No concurrent conditions, pertinent medical history, drug reactions / allergies nor concomitant medications were reported. On 05-MAR-2018, the patient was vaccinated with the first dose of GARDASIL 9 (Lot # N001533, expiration date 16-OCT-2019, dosage, route of administration and anatomical location were not reported) as routine vaccination. On approximately May 2018 (reported as within the last week) the patient experienced "being sick with a cold", clarified as "respiratory issue, most likely allergies" (Allergic respiratory symptom). No treatment was given for the adverse event, no lab diagnostic/ studies were performed, the patient did not seek for medical attention. At the time of reporting, the outcome of Allergic respiratory symptom was reported as not recovered/not resolved. The reporter did not assess the causal relationship between the adverse event and the vaccination with GARDASIL 9.
The next day after taking vaccine patient could not walk, was weak, had extreme case of fatigue, and developed a itch that has not gone away.